Literature DB >> 18939390

Using biochemical markers of bone turnover in clinical practice.

Frederick R Singer1, David R Eyre.   

Abstract

Biochemical markers of bone turnover provide clinically useful evidence of the normal and pathologic processes that reflect bone cell activity in the skeleton. Understanding the behavior of markers of bone formation and bone resorption should aid in managing patients with a variety of skeletal disorders.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18939390     DOI： 10.3949/ccjm.75.10.739

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


  31 in total

1.  Osteoporosis and gastrointestinal disease.

Authors:  Seymour Katz; Stuart Weinerman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-08

Review 2.  Bone turnover markers: use in osteoporosis.

Authors:  Kim Naylor; Richard Eastell
Journal:  Nat Rev Rheumatol       Date:  2012-06-05       Impact factor: 20.543

3.  Participation of sex hormones in multifactorial pathogenesis of adolescent idiopathic scoliosis.

Authors:  Aleksandra Kulis; Anna Goździalska; Jagoda Drąg; Jerzy Jaśkiewicz; Małgorzata Knapik-Czajka; Ewa Lipik; Daniel Zarzycki
Journal:  Int Orthop       Date:  2015-03-25       Impact factor: 3.075

4.  The effect of PTH(1-84) or strontium ranelate on bone formation markers in postmenopausal women with primary osteoporosis: results of a randomized, open-label clinical trial.

Authors:  J M Quesada-Gómez; C Muschitz; J Gómez-Reino; H Greisen; H S Andersen; H P Dimai
Journal:  Osteoporos Int       Date:  2010-10-30       Impact factor: 4.507

5.  Rapid Onset and Sustained Efficacy (ROSE) study: results of a randomised, multicentre trial comparing the effect of zoledronic acid or alendronate on bone metabolism in postmenopausal women with low bone mass.

Authors:  P Hadji; D Gamerdinger; W Spieler; P H Kann; H Loeffler; K Articus; R Möricke; V Ziller
Journal:  Osteoporos Int       Date:  2011-03-26       Impact factor: 4.507

6.  Relationship of Bone Metabolism Biomarkers and Periodontal Disease: The Osteoporotic Fractures in Men (MrOS) Study.

Authors:  Ulrike Schulze-Späte; Ryan Turner; Ying Wang; Raylien Chao; P Christian Schulze; Kathy Phipps; Eric Orwoll; Thuy-Tien Dam
Journal:  J Clin Endocrinol Metab       Date:  2015-04-09       Impact factor: 5.958

Review 7.  Benefits and limitations of bone mineral density and bone turnover markers to monitor patients treated for osteoporosis.

Authors:  E Michael Lewiecki
Journal:  Curr Osteoporos Rep       Date:  2010-03       Impact factor: 5.096

Review 8.  Can bisphosphonates play a role in the treatment of children with chronic kidney disease?

Authors:  Dieter Haffner; Dagmar-Christiane Fischer
Journal:  Pediatr Nephrol       Date:  2011-01-27       Impact factor: 3.714

9.  Taxonomy of rare genetic metabolic bone disorders.

Authors:  L Masi; D Agnusdei; J Bilezikian; D Chappard; R Chapurlat; L Cianferotti; J-P Devolgelaer; A El Maghraoui; S Ferrari; M K Javaid; J-M Kaufman; U A Liberman; G Lyritis; P Miller; N Napoli; E Roldan; S Papapoulos; N B Watts; M L Brandi
Journal:  Osteoporos Int       Date:  2015-06-13       Impact factor: 4.507

10.  The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.

Authors:  C Gao; J Qiao; S S Li; W J Yu; J W He; W Z Fu; Z L Zhang
Journal:  Osteoporos Int       Date:  2016-07-28       Impact factor: 4.507
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.